How to reconstitute Tirzepatide — visual step-by-step

What is reconstitution and why it matters for Tirzepatide

Tirzepatide is a dual GIP/GLP-1 receptor agonist — a 39-amino-acid peptide that activates both gastric inhibitory polypeptide and glucagon-like peptide-1 receptors. Research vials of tirzepatide are supplied as lyophilized powder, typically in 5 mg or 10 mg quantities. Lyophilization preserves potency during shipping and storage, but the peptide cannot be used in any research application until it has been reconstituted in a suitable sterile diluent. Because tirzepatide research protocols frequently involve weekly dosing schedules with precise volume draws, accurate reconstitution is essential for reproducible results. This guide walks through the complete process with SVG-illustrated steps.

Internal links: see the Tirzepatide peptide profile at /peptides/tirzepatide, the related dosage guide for research-dose reference, and /methodology.

Materials required

Gather: (1) Tirzepatide research vial — commonly 5 mg or 10 mg lyophilized powder. (2) Bacteriostatic water for injection, 30 mL multi-dose vial. (3) Two 1 mL insulin syringes (U-100 calibration). (4) Two 70% isopropyl alcohol swabs. (5) Clean, flat work surface. (6) Sharps disposal container. (7) Permanent marker and label for vial dating. (8) Small cooler or refrigerator for immediate storage after reconstitution — tirzepatide is temperature-sensitive once dissolved.

Step-by-step reconstitution protocol

Step 1 — Verify and lay out materials (see Diagram 1)

Confirm the tirzepatide vial shows white or off-white lyophilized powder with no visible moisture, clumping (beyond the lyophilized cake), or discoloration. Confirm the BAC water is clear, within date, and sealed. Wash hands for 20 seconds with soap and water.

Step 2 — Swab both septa (see Diagram 2)

Wipe the rubber septum of the BAC water vial with an alcohol swab using a single outward stroke. Allow 10–15 seconds to dry. Repeat with a fresh swab on the tirzepatide vial septum. Do not re-touch the swabbed area. Both septa must be fully dry before needle insertion.

Step 3 — Draw bacteriostatic water (see Diagram 3)

Insert a fresh needle through the center of the BAC water septum. Invert the BAC water vial and draw the calculated volume. For a 5 mg tirzepatide vial: adding 1.0 mL gives 5,000 mcg/mL; adding 2.0 mL gives 2,500 mcg/mL. For a 10 mg vial: 2.0 mL gives 5,000 mcg/mL. Choose the volume that places your research draw volume in a comfortable syringe range. Draw slowly and confirm no air bubbles.

Step 4 — Introduce water into the tirzepatide vial (see Diagram 4)

Tilt the tirzepatide vial at approximately 45 degrees. Insert the needle through the septum and direct the tip toward the inner glass wall. Introduce the bacteriostatic water slowly and steadily down the wall — never jet it directly onto the powder cake. Tirzepatide’s complex dual-agonist peptide structure can be disrupted by mechanical agitation. Once the liquid is introduced, remove the needle.

Step 5 — Gently swirl to dissolve

Roll the vial gently between your palms for 20–30 seconds. Do not shake or vortex. Tirzepatide dissolves into a clear, colorless to slightly yellow solution. Minor coloration is normal for this peptide; cloudiness or visible particulates are not.

Step 6 — Label and refrigerate immediately (see Diagram 5)

Label the vial with peptide name, concentration, reconstitution date, and expiry (28 days). Place the vial in the refrigerator at 2–8°C immediately. Tirzepatide in solution should not be left at room temperature for extended periods. Do not freeze the reconstituted solution.

Dose math: translating research doses to U-100 syringe units

Example — 5 mg vial in 2.0 mL BAC water: concentration = 2,500 mcg/mL = 25 mcg per unit on a U-100 syringe. Research dose of 2,500 mcg = 100 units (1 full syringe). Research dose of 5,000 mcg = 200 units (two draws). Example — 5 mg in 1.0 mL: concentration = 5,000 mcg/mL = 50 mcg per unit. A 2,500 mcg dose = 50 units. Always verify your reconstitution volume before calculating draws. Tirzepatide weekly research doses in published studies have ranged from 2.5 mg to 15 mg (2,500–15,000 mcg).

Storage post-reconstitution

Reconstituted tirzepatide: refrigerate at 2–8°C for up to 28 days in bacteriostatic water. Protect from light. Do not freeze. Per Eli Lilly prescribing information for the approved product, tirzepatide solutions are stable for 21 days at refrigerator temperature; for research vials in BAC water, 28 days is the standard guideline assuming proper preparation and storage.

Common mistakes to avoid

Frequently asked questions